Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

China approves first domestically produced nine-valent HPV vaccine

Xinhua | Updated: 2025-05-30 16:14
Share
Share - WeChat

XIAMEN -- China approved its first domestically developed nine-valent human papillomavirus (HPV) vaccine on Thursday, according to the National Medical Products Administration.

The vaccine, Cecolin 9, was jointly developed by the Xiang An Biomedicine Laboratory, Xiamen University and Wantai BioPharm. Its approval makes China the second country in the world — after the United States — with the capability to independently supply high-valency HPV vaccines.

Since 2019, the vaccine has been through five clinical trials conducted across China, involving more than 11,000 healthy volunteers aged nine to 45.

Results from these trials showed that the vaccine provides strong protection against HPV types 16 and 18 — the same strains covered by the two-valent vaccine — as well as five other HPV types 31, 33, 45, 52 and 58, with a protection rate of over 98 percent against persistent infections lasting more than 12 months and a 100 percent protection rate against cervical infections.

For girls aged nine to 17, just two doses are sufficient to produce an immune response comparable to that seen in women aged 18 to 26 who receive three doses. For girls aged 15 to 17, it is currently the only two-dose HPV vaccine available in China.

A comparative study showed that the new vaccine offers immune responses comparable with similar international products for at least 30 months after full immunization. These findings have been published in The Lancet Infectious Diseases.

The new vaccine is the latest achievement from the research team that also developed China's first domestically made two-valent HPV vaccine in 2019. In 2021, the two-valent HPV vaccine received prequalification from the World Health Organization (WHO) and has since entered the markets of 21 countries.

Cervical cancer was the fourth most common cancer among women worldwide in 2022, according to the WHO. China made free HPV vaccination accessible to approximately 40 percent of girls aged 13 to 14 in 2024, as part of its ongoing work to tackle cervical cancer, according to the National Health Commission.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 国产精品毛片a∨一区二区三区| 疯狂做受XXXX国产| 国语对白做受XXXXX在线中国| 亚洲av无码精品色午夜果冻不卡| 色噜噜视频影院| 国产精品亚洲а∨无码播放不卡| 中文字幕日韩亚洲| 欧美高清色视频在线播放| 国产午夜福利片| 2022国产精品手机在线观看| 小明天天看成人免费看| 久久国产成人精品国产成人亚洲| 狠狠躁夜夜躁人人爽天天不卡软件| 国产无遮挡色视频免费视频| 99精品在线播放| 成人毛片一区二区| 久久波多野结衣| 激情射精爆插热吻无码视频| 国产aⅴ无码专区亚洲av| 日本阿v精品视频在线观看| 婷婷五月综合缴情在线视频| 久久亚洲国产成人精品性色| 欧美另类精品xxxx人妖换性| 亚洲黄色网址在线观看| 美女内射毛片在线看3D | 亚洲入口无毒网址你懂的| 天堂/在线中文在线资源官网 | 国产香蕉精品视频| 一区三区三区不卡| 无码高潮少妇毛多水多水免费| 亚洲成A人片在线观看无码 | 亚洲白色白色永久观看| 精品国产自在在线在线观看| 国产亚洲精品bt天堂精选| 欧美精品综合一区二区三区| 国产精品视频免费一区二区| awazliksikix小吃大全图片| 少妇饥渴XXHD麻豆XXHD骆驼| 久久精品小视频| 欧美剧情影片在线播放| 八区精品色欲人妻综合网|